We are very pleased to share our publication in PLoS Pathogens (@PLOSPathogens) (doi.org/10.1371/journal.ppat…. Our team explored a Streptomyces natural product, called dealanylascamycin (DACM). We showed it is a highly mechanism of action.

Jul 10, 2025 · 3:47 AM UTC

3
4
17
538
Great work from Nat Ketprasit @nkprst, Chia-Wei Tai, Winnie Ye, Con Dogovski, Mike Griffin, Stanley Xie, University of Melbourne (@Bio21) & Monash Institute of Pharmaceutical Sciences, and colleagues from The Australian Synchrotron, Griffith University, IIT Bombay & ICGEB, India.
5
197
Sort replies: Relevant Recent Liked